Single gel application may speed healing of diabetic foot wounds
NCT ID NCT07206862
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a gel called DEBRICHEM® that is applied once to chronic diabetic foot ulcers to remove biofilm and help the wound heal. About 242 adults with foot ulcers that have not improved for at least 4 weeks will be randomly assigned to receive standard wound care plus the gel or standard care alone. The main goal is to see if more people achieve complete wound healing by 20 weeks with the gel.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DEBRICHEM® (a desiccant gel applied once to chemically debride the wound)
What this could lead to
If it works, this gel could help diabetic foot ulcers heal faster and reduce the risk of infection, hospitalization, or amputation.
What could go wrong
This is an early-stage trial with no phase designation, so results are uncertain. The gel is applied only once, and its benefit over standard care alone is not yet proven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCER (DFU) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••